Biohaven Ltd (NYSE:BHVN) has a beta value of 4.15 and has seen 0.47 million shares traded in the recent trading session. The company, currently valued at $2.40B, closed the recent trade at $23.53 per share which meant it lost -$0.51 on the day or -2.12% during that session. The BHVN stock price is -136.8% off its 52-week high price of $55.72 and 8.75% above the 52-week low of $21.47. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.1 million shares traded. The 3-month trading volume is 1.01 million shares.
The consensus among analysts is that Biohaven Ltd (BHVN) is Buy stock at the moment, with a recommendation rating of 1.12. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 7 have rated it as a Hold, with 7 advising it as a Buy. 0 have rated the stock as Underweight.
Biohaven Ltd (NYSE:BHVN) trade information
Sporting -2.12% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the BHVN stock price touched $23.53 or saw a rise of 22.11%. Year-to-date, Biohaven Ltd shares have moved -37.00%, while the 5-day performance has seen it change -21.23%. Over the past 30 days, the shares of Biohaven Ltd (NYSE:BHVN) have changed -26.61%. Short interest in the company has seen 7.33 million shares shorted with days to cover at 6.64.
Wall Street analysts have a consensus price target for the stock at $60.5, which means that the shares’ value could jump 61.11% from the levels at last check today. The projected low price target is $57.0 while the price target rests at a high of $65.0. In that case, then, we find that the latest price level in today’s session is -176.24% off the targeted high while a plunge would see the stock gain -142.24% from the levels at last check today.
Biohaven Ltd (BHVN) estimates and forecasts
The company’s shares have lost -53.86% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -49.78% over the past 5 years. Earnings growth for 2025 is a modest 26.44% while over the next 5 years, the company’s earnings are expected to increase by 22.04%.
BHVN Dividends
Biohaven Ltd is expected to release its next earnings report on 2025-Mar-02 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Biohaven Ltd (NYSE:BHVN)’s Major holders
Insiders own 11.97% of the company shares, while shares held by institutions stand at 91.81% with a share float percentage of 104.30%. Investors are also buoyed by the number of investors in a company, with Biohaven Ltd having a total of 345.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 7.27 million shares worth more than $252.41 million. As of 2024-06-30, VANGUARD GROUP INC held 8.9114% of shares outstanding.
The other major institutional holder is STIFEL FINANCIAL CORP, with the holding of over 6.48 million shares as of 2024-06-30. The firm’s total holdings are worth over $224.94 million and represent 7.3839% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF. As of Dec 31, 2024, the former fund manager holds about 2.46% shares in the company for having 2.51 shares of worth $59.3 million while later fund manager owns 2.21 shares of worth $52.27 million as of Feb 28, 2025, which makes it owner of about 2.17% of company’s outstanding stock.
